Literature DB >> 35156805

Structural Insights into Molecular Recognition by Human Chemokine CCL19.

Eric M Lewandowski1, Kyle G Kroeck1, Lian M C Jacobs1, Tyler G Fenske2, Robin N Witt3, Alyssa M Hintz3, Elizabeth R Ramsden3, Xiujun Zhang1, Francis Peterson2, Brian F Volkman2, Christopher T Veldkamp3, Yu Chen1.   

Abstract

The human chemokines CCL19 and CCL21 bind to the G protein-coupled receptor (GPCR) CCR7 and play an important role in the trafficking of immune cells as well as cancer metastasis. Conserved binding sites for sulfotyrosine residues on the receptor contribute significantly to the chemokine/GPCR interaction and have been shown to provide promising targets for new drug-discovery efforts to disrupt the chemokine/GPCR interaction and, consequently, tumor metastasis. Here, we report the first X-ray crystal structure of a truncated CCL19 (residues 7-70) at 2.50 Å resolution, revealing molecular details crucial for protein-protein interactions. Although the overall structure is similar to the previously determined NMR model, there are important variations, particularly near the N terminus and the so-called 30's and 40's loops. Computational analysis using the FTMap server indicates the potential importance of these areas in ligand binding and the differences in binding hotspots compared to CCL21. NMR titration experiments using a CCR7-derived peptide (residues 5-11, TDDYIGD) further demonstrate potential receptor recognition sites, such as those near the C terminus and 40's loop, which consist of both positively charged and hydrophobic residues that may be important for receptor binding. Taken together, the X-ray, NMR, and computational analysis herein provide insights into the overall structure and molecular features of CCL19 and enables investigation into this chemokine's function and inhibitor development.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35156805      PMCID: PMC9254573          DOI: 10.1021/acs.biochem.1c00759

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.321


  39 in total

1.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

2.  Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton.

Authors:  Paul U Cameron; Suha Saleh; Georgina Sallmann; Ajantha Solomon; Fiona Wightman; Vanessa A Evans; Genevieve Boucher; Elias K Haddad; Rafick-Pierre Sekaly; Andrew N Harman; Jenny L Anderson; Kate L Jones; Johnson Mak; Anthony L Cunningham; Anthony Jaworowski; Sharon R Lewin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-13       Impact factor: 11.205

3.  Production of Recombinant Chemokines and Validation of Refolding.

Authors:  Christopher T Veldkamp; Chad A Koplinski; Davin R Jensen; Francis C Peterson; Kaitlin M Smits; Brittney L Smith; Scott K Johnson; Christina Lettieri; Wallace G Buchholz; Joyce C Solheim; Brian F Volkman
Journal:  Methods Enzymol       Date:  2015-11-14       Impact factor: 1.600

4.  Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1.

Authors:  M P Crump; J H Gong; P Loetscher; K Rajarathnam; A Amara; F Arenzana-Seisdedos; J L Virelizier; M Baggiolini; B D Sykes; I Clark-Lewis
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

5.  Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12.

Authors:  Christopher T Veldkamp; Christoph Seibert; Francis C Peterson; Norberto B De la Cruz; John C Haugner; Harihar Basnet; Thomas P Sakmar; Brian F Volkman
Journal:  Sci Signal       Date:  2008-09-16       Impact factor: 8.192

6.  Tyrosine sulfation of chemokine receptor CCR2 enhances interactions with both monomeric and dimeric forms of the chemokine monocyte chemoattractant protein-1 (MCP-1).

Authors:  Joshua H Y Tan; Justin P Ludeman; Jamie Wedderburn; Meritxell Canals; Pam Hall; Stephen J Butler; Deni Taleski; Arthur Christopoulos; Michael J Hickey; Richard J Payne; Martin J Stone
Journal:  J Biol Chem       Date:  2013-02-13       Impact factor: 5.157

Review 7.  CCR7 and its ligands: balancing immunity and tolerance.

Authors:  Reinhold Förster; Ana Clara Davalos-Misslitz; Antal Rot
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

8.  The solution structure of monomeric CCL5 in complex with a doubly sulfated N-terminal segment of CCR5.

Authors:  Meital Abayev; João P G L M Rodrigues; Gautam Srivastava; Boris Arshava; Łukasz Jaremko; Mariusz Jaremko; Fred Naider; Michael Levitt; Jacob Anglister
Journal:  FEBS J       Date:  2018-04-20       Impact factor: 5.542

Review 9.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

10.  Differential ligand-signaling network of CCL19/CCL21-CCR7 system.

Authors:  Rajesh Raju; Sachin Gadakh; Priyanka Gopal; Bijesh George; Jayshree Advani; Sowmya Soman; T S K Prasad; Reshmi Girijadevi
Journal:  Database (Oxford)       Date:  2015-10-26       Impact factor: 3.451

View more
  1 in total

1.  Screening of Sepsis Biomarkers Based on Bioinformatics Data Analysis.

Authors:  Guibin Liang; Jiuang Li; Shiqian Pu; Zhihui He
Journal:  J Healthc Eng       Date:  2022-09-26       Impact factor: 3.822

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.